Searched for
PHARMACEUTICAL ACQUISITIONS 2023
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Over 60% of pharma MSMEs yet to comply with updated manufacturing normsPharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- India’s realty equity inflows hit record $30.7 billion between 2024-Q1 2026Between 2024 and early 2026, India’s real estate landscape witnessed an astonishing influx of over $30 billion in equity capital, showcasin...
- Sun Pharma-Organon deal: How a $12-billion merger will reshape India's pharma landscapeSun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...
- India to attract major share of EQT's $15.6-billion Asia fund: EQT India headEQT expects India to remain a top capital destination in its new Asia fund, with roughly one-third allocation historically. The firm sees s...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- Acquisition count rises: Inside OpenAI's major deals in 2026The AI major’s half a dozen deals in the first quarter underscore its push to strengthen its position across enterprise software, developer...
- Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...
- US-based AptarGroup breaks ground for new pharma plant in Taloja, near MumbaiAptarGroup held a groundbreaking ceremony for a new pharmaceutical plant in Taloja, India. The facility expands AptarGroup's presence in th...
- Kotak Fund to part finance matrix lab founder's Viatris buyThe fund plans to provide a $150 million mezzanine debt facility at 18-20% and arrange another $300 million from other lenders to finance t...
- Nirma to raise Rs 3,500 cr via bonds, pay upto 8.5%Nirma entered into a deal with listed Glenmark Pharmaceuticals in September 2023 to buy a 75% stake in Glenmark Life Sciences for ₹5,650 cr...
- Akums Drugs files draft IPO papers with Sebi; eyes Rs 680 cr via fresh issueThe company is looking to raise Rs 136 crore through a pre-IPO placement. If such placement is undertaken, then fresh issue size will be re...
- Nirma hires managers to raise Rs 3,500-crore NCDs to finance Glenmark Life SciencesNirma has proposed to raise the debt in the form of rated, listed, non-convertible debentures (NCD) for a term of one, two and three years,...
- Pharma Sector: ICRA expects 9-11% growth in FY24 led by new launches, US reboundCredit rating agency ICRA predicts that the revenues of 25 Indian pharmaceutical companies, which account for 60% of the Indian pharmaceuti...
- Buy J B Chemicals & Pharmaceuticals, target price Rs 1,800: Prabhudas LilladherJBCP’s long term growth drivers remain intact led by 1) geographical expansion of legacy brands 2) improvement in MR productivity 3) scale-...
- JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 croreJB will pay Rs 964 crore for the portfolio licensing agreement with Novartis Innovative Therapies AG which the company said is "perpetual i...
- CCI approves Nirma's acquisition of Glenmark Life SciencesThe acquisition will trigger a mandatory open offer to all public shareholders of GLS for an additional 17%.
- Sun Pharma offers to acquire 100% stake in Taro in an all-cash dealThe proposed acquisition does not include shares held by Sun Pharma and its affiliates. After the completion of the deal, Sun Pharma will h...
- Lupin to acquire French firm Medisol for around Rs 160 crPharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...
Load More
